228 related articles for article (PubMed ID: 38172896)
41. The Influence of Left Atrial Enlargement on the Relationship between Atrial Fibrillation and Stroke.
Broughton ST; O'Neal WT; Salahuddin T; Soliman EZ
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1396-402. PubMed ID: 27012217
[TBL] [Abstract][Full Text] [Related]
42. The co-predictive value of a cardiovascular score for CV outcomes in diabetic patients with no atrial fibrillation.
Patti G; Sticchi A; Pasceri V; Ricci F; Renda G; Hamrefors V; Melander O; Sutton R; Engström G; De Caterina R; Fedorowski A
Diabetes Metab Res Rev; 2019 Jul; 35(5):e3145. PubMed ID: 30790434
[TBL] [Abstract][Full Text] [Related]
43. Associations Between Alcohol Intake and Genetic Predisposition With Atrial Fibrillation Risk in a National Biobank.
Halford JL; Weng LC; Choi SH; Jurgens SJ; Morrill VN; Khurshid S; Trinquart L; Benjamin EJ; Ellinor PT; Lubitz SA
Circ Genom Precis Med; 2020 Dec; 13(6):e003111. PubMed ID: 33156697
[TBL] [Abstract][Full Text] [Related]
44. European and US Guideline-Based Statin Eligibility, Genetically Predicted Coronary Artery Disease, and the Risk of Major Coronary Events.
Park H; Kim D; You SC; Jang E; Yu HT; Kim TH; Kim DM; Sung JH; Pak HN; Lee MH; Yang PS; Joung B
J Am Heart Assoc; 2024 May; 13(9):e032831. PubMed ID: 38639378
[TBL] [Abstract][Full Text] [Related]
45. Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII.
Olivieri O; Cappellari M; Turcato G; Bonetti B; Girelli D; Pizzolo F; Friso S; Bassi A; Castagna A; Martinelli N
Stroke; 2020 Jan; 51(1):61-68. PubMed ID: 31795904
[TBL] [Abstract][Full Text] [Related]
46. Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Dipeptidyl Peptidase-4 Inhibitor on the Risks of New-Onset Atrial Fibrillation, Stroke and Mortality in Diabetic Patients: A Propensity Score-Matched Study in Hong Kong.
Lee S; Zhou J; Leung KSK; Wai AKC; Jeevaratnam K; King E; Liu T; Wong WT; Chang C; Wong ICK; Cheung BMY; Tse G; Zhang Q
Cardiovasc Drugs Ther; 2023 Jun; 37(3):561-569. PubMed ID: 35142921
[TBL] [Abstract][Full Text] [Related]
47. Antithrombotic therapy in coronary artery disease patients with atrial fibrillation.
Wei L; Su E; Liu W; Xing W; Liu X; Zhang Y; Wang S; Cheng Q; Qi D; Gao C
BMC Cardiovasc Disord; 2020 Jul; 20(1):323. PubMed ID: 32631244
[TBL] [Abstract][Full Text] [Related]
48. A polygenic risk score predicts atrial fibrillation in cardiovascular disease.
Marston NA; Garfinkel AC; Kamanu FK; Melloni GM; Roselli C; Jarolim P; Berg DD; Bhatt DL; Bonaca MP; Cannon CP; Giugliano RP; O'Donoghue ML; Raz I; Scirica BM; Braunwald E; Morrow DA; Ellinor PT; Lubitz SA; Sabatine MS; Ruff CT
Eur Heart J; 2023 Jan; 44(3):221-231. PubMed ID: 35980763
[TBL] [Abstract][Full Text] [Related]
49. Reproducible disease phenotyping at scale: Example of coronary artery disease in UK Biobank.
Patel RS; Denaxas S; Howe LJ; Eggo RM; Shah AD; Allen NE; Danesh J; Hingorani A; Sudlow C; Hemingway H
PLoS One; 2022; 17(4):e0264828. PubMed ID: 35381005
[TBL] [Abstract][Full Text] [Related]
50. Prognostic implications of atrial fibrillation in patients with stable coronary artery disease: a systematic review and meta-analysis of adjusted observational studies.
Saglietto A; Varbella V; Ballatore A; Xhakupi H; Ferrari GM; Anselmino M
Rev Cardiovasc Med; 2021 Jun; 22(2):439-444. PubMed ID: 34258910
[TBL] [Abstract][Full Text] [Related]
51. C-reactive protein gene polymorphism predicts the risk of thromboembolic stroke in patients with atrial fibrillation: a more than 10-year prospective follow-up study.
Chang SN; Lai LP; Chiang FT; Lin JL; Hwang JJ; Tsai CT
J Thromb Haemost; 2017 Aug; 15(8):1541-1546. PubMed ID: 28498565
[TBL] [Abstract][Full Text] [Related]
52. Risk prediction of atrial fibrillation in the community combining biomarkers and genetics.
Börschel CS; Ohlrogge AH; Geelhoed B; Niiranen T; Havulinna AS; Palosaari T; Jousilahti P; Rienstra M; van der Harst P; Blankenberg S; Zeller T; Salomaa V; Schnabel RB
Europace; 2021 May; 23(5):674-681. PubMed ID: 33458771
[TBL] [Abstract][Full Text] [Related]
53. Atrial Fibrillation and Cause-Specific Risks of Pulmonary Embolism and Ischemic Stroke.
Hald EM; Rinde LB; Løchen ML; Mathiesen EB; Wilsgaard T; Njølstad I; Brækkan SK; Hansen JB
J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29378729
[TBL] [Abstract][Full Text] [Related]
54. Excessive Atrial Ectopy and Short Atrial Runs Increase the Risk of Stroke Beyond Incident Atrial Fibrillation.
Larsen BS; Kumarathurai P; Falkenberg J; Nielsen OW; Sajadieh A
J Am Coll Cardiol; 2015 Jul; 66(3):232-241. PubMed ID: 26184616
[TBL] [Abstract][Full Text] [Related]
55. Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial.
Damask A; Steg PG; Schwartz GG; Szarek M; Hagström E; Badimon L; Chapman MJ; Boileau C; Tsimikas S; Ginsberg HN; Banerjee P; Manvelian G; Pordy R; Hess S; Overton JD; Lotta LA; Yancopoulos GD; Abecasis GR; Baras A; Paulding C;
Circulation; 2020 Feb; 141(8):624-636. PubMed ID: 31707832
[TBL] [Abstract][Full Text] [Related]
56. Associations of Fitness, Physical Activity, Strength, and Genetic Risk With Cardiovascular Disease: Longitudinal Analyses in the UK Biobank Study.
Tikkanen E; Gustafsson S; Ingelsson E
Circulation; 2018 Jun; 137(24):2583-2591. PubMed ID: 29632216
[TBL] [Abstract][Full Text] [Related]
57. Should the Presence or Extent of Coronary Artery Disease be Quantified in the CHA2DS2-VASc Score in Atrial Fibrillation? A Report from the Western Denmark Heart Registry.
Steensig K; Olesen KKW; Thim T; Nielsen JC; Jensen SE; Jensen LO; Kristensen SD; Bøtker HE; Lip GYH; Maeng M
Thromb Haemost; 2018 Dec; 118(12):2162-2170. PubMed ID: 30419601
[TBL] [Abstract][Full Text] [Related]
58. Integration of a polygenic score into guideline-recommended prediction of cardiovascular disease.
Li L; Pang S; Starnecker F; Mueller-Myhsok B; Schunkert H
Eur Heart J; 2024 May; 45(20):1843-1852. PubMed ID: 38551411
[TBL] [Abstract][Full Text] [Related]
59. Association between myeloperoxidase and the risks of ischemic stroke, heart failure, and atrial fibrillation: A Mendelian randomization study.
Wang Y; Jia Y; Xu Q; Wang R; Sun L; Guo D; Shi M; Yang P; Wang Y; Liu F; Zhang Y; Zhu Z
Nutr Metab Cardiovasc Dis; 2023 Jan; 33(1):210-218. PubMed ID: 36411224
[TBL] [Abstract][Full Text] [Related]
60. Associations between polygenic risk of coronary artery disease and type 2 diabetes, lifestyle, and cardiovascular mortality: A prospective UK Biobank study.
Yun JS; Jung SH; Shivakumar M; Xiao B; Khera AV; Park WY; Won HH; Kim D
Front Cardiovasc Med; 2022; 9():919374. PubMed ID: 36061534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
